Compliance With Antibiotic Treatment in General Practice

The guidelines of The Norwegian authorities concerning the use of antibiotics in general practice state that for several common diseases such as pneumonia and tonsillitis, antibiotics should be given four times daily instead of three times daily. The study´s aim is to see whether the patient compliance is significantly reduced in antibiotic regimes of 3 or 4 daily doses as compared to 1 or 2 daily doses.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patient Compliance Behavior Health Behavior Patient Acceptance of Health Care Treatment Adherence and Compliance

Sex eligibility

All sexes

Study type

Observational

Primary location

Hisøy legekontor, Arendal, Aust-Agder, Norway

About this study

All patients given antibiotic tablets, independent of diagnosis and medicament, are included. All patients give a written consent. Within a week after the end of the treatment all patients are contacted by one of the authors and asked a few standardized questions concerning their compliance with the treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Any patient given antibiotics for any cause

Exclusion criteria

Use of mixture instead of tablets
Tablets administrated by public health care services

Sponsors and collaborators

Lead sponsor

Norwegian Medical Association

Other

Registry information

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2012
First posted: Feb 8, 2011
Registry last updated: Apr 24, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed